Effect of adrenomedullin gene delivery on insulin resistance in type 2 diabetic rats

Journal of Advanced Research

Volumn 2, Issue 1, 2011, Pages 57-64

  Henein, Hoda Y ^a   Younan, Sandra M ^a   Rashed, Leila A ^a   Fakhry, Amy ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b Fayoum University   (Egypt)

Author keywords

Adrenomedullin; Insulin resistance; Muscle glucose uptake

Indexed keywords

EID: 79951579666     PISSN: 20901232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jare.2010.08.002     Document Type: Article

References (53)

1. Reaven G.M. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 2005, 25:391-406.
2. Rodnick K.J., Henriksen E.J., James D.E., Holloszy J.O. Exercise training, glucose transporters and glucose transport in rat skeletal muscles. Am J Physiol 1992, 262(1 Pt. 1):C9-C14.
3. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993, 192(2):553-560.
4. Shoji H., Minamino N., Kangawa K., Matsuo H. Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem Biophys Res Commun 1995, 215(2):531-537.
5. Fukai N., Yoshimoto T., Sugiyama T., Ozawa N., Sato R., Shichiri M., et al. Concomitant expression of adrenomedullin and its receptor components in rat adipose tissues. Am J Physiol Endocrinol Metab 2005, 288(1):E56-E62.
6. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993, 194(2):720-725.
7. Eto T., Kitamura K., Kato J. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin Exp Pharmacol Physiol 1999, 26(5-6):371-380.
8. Xing G., Shimosawa T., Ogihara T., Matsui H., Itakura K., Qingyou X., et al. Angiotensin II-induced insulin resistance is enhanced in adrenomedullin-deficient mice. Endocrinology 2004, 145(8):3647-3651.
9. Dobrzynski E., Montanari D., Agata J., Zhu J., Chao J., Chao L. Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 2002, 283(6):E1291-E1298.
10. Shindo T., Kurihara H., Maemura K., Kurihara Y., Kuwaki T., Izumida T., et al. Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 2000, 101(19):2309-2316.
11. Nowicki M.T., Aleksunes L.M., Sawant S.P., Dnyanmote A.V., Mehendale H.M., Manautou J.E. Renal and hepatic transporter expression in type 2 diabetic rats. Drug Metab Lett 2008, 2(1):11-17.
12. Shih P., Evans K., Schifferli K., Ciccarone V., Lichaa F., Masoud M., et al. Enhancement of lipid cationic transfections in the presence of serum. Focus 1997, 19:52.
13. Chao J., Jin L., Lin K.F., Chao L. Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertens Res 1997, 20(4):269-277.
14. Thule P.M., Campbell A.G., Kleinhenz D.J., Olson D.E., Boutwell J.J., Sutliff R.L., et al. Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats. Am J Physiol Endocrinol Metab 2006, 290(1):E114-E122.
15. Whittington K.B., Solomon S.S., Lu Z.N., Selawry H.P. Islet allografts in the cryptorchid testes of spontaneously diabetic BB/Wor dp rats: response to glucose, glipizide and arginine. Endocrinology 1991, 128(6):2671-2677.
16. Koranyi L., Tanizawa Y., Penicaud L., Atef N., Girard J., Permutt M.A. Developmental regulation of amylin and insulin-gene expression in lean (Fa/Fa) and obese (fa/fa) Zucker rats. Diabetes 1992, 41(6):685-690.
17. Sun B., Wells J., Goldmuntz E., Silver P., Remmers E.F., Wilder R.L., et al. A simplified, competitive RT-PCR method for measuring rat IFN-gamma mRNA expression. J Immunol Meth 1996, 195(1-2):139-148.
18. Ueyama A., Sato T., Yoshida H., Magata K., Koga N. Nonradioisotope assay of glucose uptake activity in rat skeletal muscle using enzymatic measurement of 2-deoxyglucose 6-phosphate in vitro and in vivo. Biol Signals Recept 2000, 9(5):267-274.
19. Shimosawa T., Ogihara T., Matsui H., Asano T., Ando K., Fujita T. Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension 2003, 41(5):1080-1085.
20. Coppock H.A., Owji A.A., Bloom S.R., Smith D.M. A rat skeletal muscle cell line (L6) expresses specific adrenomedullin binding sites but activates adenylate cyclase via calcitonin gene-related peptide receptors. Biochem J 1996, 318(Pt 1):241-245.
21. Nishimatsu H., Suzuki E., Nagata D., Moriyama N., Satonaka H., Walsh K., et al. Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta. Circ Res 2001, 89(1):63-70.
22. Matsui T., Li L., del Monte F., Fukui Y., Franke T.F., Hajjar R.J., et al. Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 1999, 100(23):2373-2379.
23. Zisman A., Peroni O.D., Abel E.D., Michael M.D., Mauvais Jarvis F., Lowell B.B., et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 2000, 6(8):924-928.
24. Goodyear L.J., Kahn B.B. Exercise, glucose transport and insulin sensitivity. Annu Rev Med 1998, 49:235-261.
25. Kern M., Wells J.A., Stephens J.M., Elton C.W., Friedman J.E., Tapscott E.B., et al. Insulin responsiveness in skeletal muscle is determined by glucose transporter (Glut4) protein level. Biochem J 1990, 270(2):397-400.
26. Garvey W.T., Maianu L., Zhu J.H., Brechtel Hook G., Wallace P., Baron A.D. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 1998, 101(11):2377-2386.
27. Bertelsen M., Anggard E.E., Carrier M.J. Oxidative stress impairs insulin internalization in endothelial cells in vitro. Diabetologia 2001, 44(5):605-613.
28. Najib S., Sanchez Margalet V. Homocysteine thiolactone inhibits insulin signaling and glutathione has a protective effect. J Mol Endocrinol 2001, 27(1):85-91.
29. Rudich A., Kozlovsky N., Potashnik R., Bashan N. Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes. Am J Physiol 1997, 272(5 Pt. 1):E935-E940.
30. Ando K., Ito Y., Kumada M., Fujita T. Oxidative stress increases adrenomedullin mRNA levels in cultured rat vascular smooth muscle cells. Hypertens Res 1998, 21(3):187-191.
31. Shimosawa T., Shibagaki Y., Ishibashi K., Kitamura K., Kangawa K., Kato S., et al. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 2002, 105(1):106-111.
32. Aragno M., Mastrocola R., Catalano M.G., Brignardello E., Danni O., Boccuzzi G. Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes 2004, 53(4):1082-1088.
33. Heiman M.L., Ahima R.S., Craft L.S., Schoner B., Stephens T.W., Flier J.S. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997, 138(9):3859-3863.
34. Chan O., Inouye K., Vranic M., Matthews S.G. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology 2002, 143(5):1761-1768.
35. Margetic S., Gazzola C., Pegg G.G., Hill R.A. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002, 26(11):1407-1433.
36. Fukushima M., Hattori Y., Tsukada H., Koga K., Kajiwara E., Kawano K., et al. Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection. J Gene Med 2007, 9(11):976-985.
37. Iemura Inaba C., Nishikimi T., Akimoto K., Yoshihara F., Minamino N., Matsuoka H. Role of adrenomedullin system in lipid metabolism and its signaling mechanism in cultured adipocytes. Am J Physiol Regul Integr Comp Physiol 2008, 295(5):R1376-R1384.
38. Dimitriadis G., Leighton B., Parry Billings M., Sasson S., Young M., Krause U., et al. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J 1997, 321(Pt 3):707-712.
39. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7(8):941-946.
40. Qi Y., Takahashi N., Hileman S.M., Patel H.R., Berg A.H., Pajvani U.B., et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004, 10(5):524-529.
41. Huang H., Park P.H., McMullen M.R., Nagy L.E. Mechanisms for the anti-inflammatory effects of adiponectin in macrophages. J Gastroenterol Hepatol 2008, 23(Suppl. 1):S50-S53.
42. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002, 290(3):1084-1089.
43. Diez J.J., Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003, 148(3):293-300.
44. Hayashi M., Shimosawa T., Fujita T. Hyperglycemia increases vascular adrenomedullin expression. Biochem Biophys Res Commun 1999, 258(2):453-456.
45. Turk H.M., Buyukberber S., Sevinc A., Ak G., Ates M., Sari R., et al. Relationship between plasma adrenomedullin levels and metabolic control, risk factors and diabetic microangiopathy in patients with type 2 diabetes. Diabetes Care 2000, 23(6):864-867.
46. Katsuki A., Sumida Y., Gabazza E.C., Murashima S., Urakawa H., Morioka K., et al. Acute hyperinsulinemia is associated with increased circulating levels of adrenomedullin in patients with type 2 diabetes mellitus. Eur J Endocrinol 2002, 147(1):71-75.
47. Katsuki A., Sumida Y., Urakawa H., Gabazza E.C., Maruyama N., Morioka K., et al. Increased oxidative stress is associated with elevated plasma levels of adrenomedullin in hypertensive patients with type 2 diabetes. Diabetes Care 2003, 26(5):1642-1643.
48. Tanaka M., Kitamura K., Ishizaka Y., Ishiyama Y., Kato J., Kangawa K., et al. Plasma adrenomedullin in various diseases and exercise-induced change in adrenomedullin in healthy subjects. Intern Med 1995, 34(8):728-733.
49. Toepfer M., Hartmann G., Schlosshauer M., Hautmann H., Tschop M., Fischer R., et al. Adrenomedullin: a player at high altitude?. Chest 1998, 113(5):1428.
50. Jerat S., Kaufman S. Effect of pregnancy and steroid hormones on plasma adrenomedullin levels in the rat. Can J Physiol Pharmacol 1998, 76(4):463-466.
51. Nagata N., Kato J., Kitamura K., Kawamoto M., Tanaka N., Eto T., et al. Dissociation of adrenomedullin concentrations in plasma and cerebrospinal fluid in pregnant and non-pregnant women. Eur J Endocrinol 1998, 139(6):611-614.
52. Mulder H., Ahren B., Karlsson S., Sundler F. Adrenomedullin: Localization in the gastrointestinal tract and effects on insulin secretion. Regul Pept 1996, 62(2-3):107-112.
53. Martinez A., Weaver C., Lopez J., Bhathena S.J., Elsasser T.H., Miller M.J., et al. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology 1996, 137(6):2626-2632.